Gelation behavior of 5-Chloro-8-hydroxyquinoline, an antituberculosis agent in aqueous alcohol solutions

Antibiotics

Volumn 1, Issue , 2012, Pages 17-24

  Kolehmainen, Erkki ^a   Salo, Hannu ^a   Korpela, Jukka ^a  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

5 chloro 8 hydroxyquinoline; Gel; Mycobacterium tuberculosis

Indexed keywords

ALCOHOL; CLOXIQUINE; DRUG SOLVENT;

ACCELERATION; ARTICLE; DRUG STABILITY; DRUG STRUCTURE; GELATION; MOLECULAR WEIGHT; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; THERMOSTABILITY; TOPOGRAPHY; TRANSITION TEMPERATURE;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84876752442     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics1010017     Document Type: Article

References (17)

1. Dye, C. Global epidemiology of tuberculosis. Lancet 2006, 367, 938-940.
2. Ahmad, Z.; Makaya, N. H.; Grosset, J. History of drug discovery: Early evaluation studies and lessons learnt from them. Prog. Respir. Res. 2011, 40, 2-9.
3. Hongmanee, P.; Rukseree, K.; Buabut, B.; Somsri, B.; Prasit, P. In vitro activities of cloxyquin (5-chloroquinolin-8-ol) against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2007, 51, 1105-1106.
4. Darby, C. M.; Nathan, C. F. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline. J. Antimicrob. Chemother. 2010, 65, 1424-1427.
5. Enquist, P.-A.; Gylfe, Å.; Hägglund, U.; Lindström, P.; Norberg-Scherman, H.; Sundin, C.; Elofsson, M. Derivatives of 8-hydroxyquinoline-Antibacterial agents that target intra-and extracellular Gram-negative pathogens. Bioorg. Med. Chem. Lett. 2012, 22, 3550-3553.
6. Ma, Z.; Moulton, B. A novel polymorph of 5-chloro-8-hydroxyquinoline with improved water solubility and faster dissolution rate. J. Chem. Crystallogr. 2009, 39, 913-918.
7. Fernández-Bachiller, M. I.; Pérez, C.; González-Munoz, G. C.; Conde, S.; López, M. G.; Villarroya, M.; García, A. G.; Rodríguez-Franco, M. I. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. J. Med. Chem. 2010, 53, 4927-4937.
8. Kharadia, G. J.; Patel, J. R.; Dholakiy, B. Z. Antituberculosis, antifungal and thermal activity of mixed ligand transition metal complexes. Appl. Organomet. Chem. 2010, 24, 821-827.
9. Ma, Z.; Moulton, B. Mixed-Ligand Coordination Species: A Promising Approach for "Second-Generation" Drug Development. Cryst. Growth Des. 2007, 7, 196-198.
10. Ma, Z.; Moulton, B. Supramolecular medicinal chemistry: Mixed-ligand coordination complexes. Mol. Pharm. 2007, 4, 373-385.
11. Pasipanodya, J. G.; Gumbo, T. A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs. Curr. Opin. Pharmacol. 2011, 11, 457-463.
12. Sangeetha, N. M.; Maitra, U. Supramolecular gels: Functions and uses. Chem. Soc. Rev. 2005, 34, 821-836.
13. Svobodová, H.; Noponen, V.; Kolehmainen, E.; Sievänen, E. Recent advances in steroidal supramolecular gels. RSC Adv. 2012, 2, 7840-7847.
14. Latosińska, J. N.; Latosińska, M.; Tomczak, M. A.; Seliger, J.; Žagar, V. Supramolecular synthon pattern in solid clioquinol and cloxiquine (APIs of antibacterial, antifungal, antiaging and antituberculosis drugs) studied by 35Cl NQR, 1H-17O and 1H-14N NQDR and DFT/QTAIM. J. Mol. Model. 2011, 17, 1781-1800.
15. Svobodová, H.; Nonappa; Lahtinen, M.; Wimmer, Z.; Kolehmainen, E. A steroid-based gelator of A(LS)2 type: Tuning gel properties by metal coordination. Soft Matter 2012, 8, 3840-3847.
16. Iqbal, S.; Rodríguez-LLansola, F.; Escuder, B.; Miravet, J. F.; Verbruggen, I.; Willemis, R. HRMAS 1H-NMR as a tool for the study of supramolecular gels. Soft Matter 2010, 6, 1875-1878.
17. Spectral Database for Organic Compounds. Available online: http://riodb01. ibase. aist. go. jp/sdbs/cgibin/cre_index. cgi?lang=eng (accessed on 18 September 2012).